Polaryx Therapeutics Inc
NASDAQ:PLYX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Polaryx Therapeutics Inc
NASDAQ:PLYX
|
US |
|
ADC Therapeutics SA
NYSE:ADCT
|
CH |
|
M
|
Magellan Financial Group Ltd
F:NNA
|
AU |
|
H
|
Home BancShares Inc
XBER:H5C
|
US |
|
S
|
Shangri-La Asia Ltd
XMUN:SHN
|
HK |
|
G
|
GungHo Online Entertainment Inc
SWB:G03
|
JP |
|
Molson Coors Canada Inc
OTC:MXGBF
|
CA |
|
I
|
Isgec Heavy Engineering Ltd
BSE:533033
|
IN |
|
D
|
Dhunseri Ventures Ltd
BSE:523736
|
IN |
|
Quixant PLC
LSE:QXT
|
UK |
Bankruptcy Probability
Polaryx Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Polaryx Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
P
|
Polaryx Therapeutics Inc
NASDAQ:PLYX
|
113.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
10.6T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
4.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
V
|
Veradermics Inc
NYSE:MANE
|
4.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Definium Therapeutics Inc
NASDAQ:DFTX
|
4.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alumis Inc
NASDAQ:ALMS
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
K
|
Kailera Therapeutics Inc
NASDAQ:KLRA
|
2.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
4T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Polaryx Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Polaryx Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
